Stem cells can form gap junctions with cardiac myocytes and exert pro-arrhythmic effects

Frontiers in Physiology

Volumn 5, Issue OCT, 2014, Pages

  Smit, N W ^a   Coronel, R ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Arrhythmias; Cardiomyocytes; Clinical trials; Electrotonic connections; Stem cells

Indexed keywords

ARRHYTHMOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CELL INTERACTION; GAP JUNCTION; HEART ARRHYTHMIA; HEART AUTOMATICITY; HEART DEPOLARIZATION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PARACRINE SIGNALING; PATIENT SAFETY; STEM CELL TRANSPLANTATION; SYMPATHETIC INNERVATION; TREATMENT OUTCOME;

EID: 84908370291     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00419     Document Type: Article

References (67)

1. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, et al. 2005. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 97 (2): 159-167.
2. Askar SF, Ramkisoensing AA, Atsma DE, Schalij MJ, de Vries AA, and Pijnappels DA. 2013. Engraftment patterns of human adult mesenchymal stem cells expose electrotonic and paracrine proarrhythmic mechanisms in myocardial cell cultures. Circ. Arrhythm. Electrophysiol. 6 (2): 380-391.
3. Beeres SL, Atsma DE, van der Laarse A, Pijnappels DA, van TJ, Fibbe WE, de Vries AA, et al. 2005. Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J. Am. Coll. Cardiol. 46 (10): 1943-1952.
4. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al. 2011. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378 (9806): 1847-1857.
5. Bursac N, Kirkton RD, McSpadden LC, and Liau B. 2010. Characterizing functional stem cell cardiomyocyte interactions. Regen. Med. 5 (1): 87-105.
6. Cao JM, Chen LS, Kenknight BH, Ohara T, Lee MH, Tsai J, et al. 2000. Nerve sprouting and sudden cardiac death. Circ. Res. 86 (7): 816-821.
7. Chang MG, Tung L, Sekar RB, Chang CY, Cysyk J, Dong P, Marban E, et al. 2006. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 113 (15): 1832-1841.
8. Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ, et al. 2014. Human embryonic stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510 (7504): 273-277.
9. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, et al. 2012. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126 (11 Suppl 1): S54-S64.
10. Coronel R, Wilders R, Verkerk AO, Wiegerinck RF, Benoist D, and Bernus O. 2013. Electrophysiological changes in heart failure and their implications for arrhythmogenesis. Biochim. Biophys. Acta 1832 (12): 2432-2441.
11. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de JN, et al. 1993. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation 88 (3): 915-926.
12. de Bakker JM, and Wittkampf FH. 2010. The pathophysiologic basis of fractionated and complex electrograms and the impact of recording techniques on their detection and interpretation. Circ. Arrhythm. Electrophysiol. 3 (2): 204-213.
13. de Groot JR, Veenstra T, Verkerk AO, Wilders R, Smits JP, Wilms-Schopman FJ, et al. 2003. Conduction slowing by the gap junctional uncoupler carbenoxolone. Cardiovasc. Res. 60 (2): 288-297.
14. de Diego C, Pai RK, Chen F, Xie LH, De LJ, Weiss JN, et al. 2008. Electrophysiological consequences of acute regional ischemia/reperfusion in neonatal rat ventricular myocyte monolayers. Circulation 118 (23): 2330-2337.
15. de Jong R, Houtgraaf JH, Samiei S, Boersma E, and Duckers HJ. 2014. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ. Cardiovasc. Interv. 7 (2): 156-167.
16. Dhein S. 2004. Pharmacology of gap junctions in the cardiovascular system. Cardiovasc. Res. 62 (2): 287-298.
17. Duffy HS. 2008. Cardiac connections--the antiarrhythmic solution? N. Engl. J. Med. 358 (13): 1397-1398.
18. Eisen HJ. 2008. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 5 (9): 520-521.
19. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, and Martin-Rendon E. 2014. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane. Database. Syst. Rev. 4: CD007888.
20. Gnecchi M, Zhang Z, Ni A, and Dzau VJ. 2008. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103 (11): 1204-1219.
21. Henriquez AP, Vogel R, Muller-Borer BJ, Henriquez CS, Weingart R, and Cascio WE. 2001. Influence of dynamic gap junction resistance on impulse propagation in ventricular myocardium: a computer simulation study. Biophys. J. 81 (4): 2112-2121.
22. Heubach JF, Graf EM, Leutheuser J, Bock M, Balana B, Zahanich I, et al. 2004. Electrophysiological properties of human mesenchymal stem cells. J. Physiol 554 (Pt 3): 659-672.
23. Hondeghem LM, Carlsson L, and Duker G. 2001. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 103 (15): 2004-2013.
24. Hubbard ML, Ying W, and Henriquez CS. 2007. Effect of gap junction distribution on impulse propagation in a monolayer of myocytes: a model study. Europace. 9 Suppl 6: vi20-vi28.
25. Jongsma HJ, and Wilders R. 2000. Gap junctions in cardiovascular disease. Circ. Res. 86 (12): 1193-1197.
26. Jonsson MK, Wang QD, and Becker B. 2011. Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. Assay. Drug Dev. Technol. 9 (6): 589-599.
27. Kanno S, and Saffitz JE. 2001. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc. Pathol. 10 (4): 169-177.
28. Kawano H, Okada R, and Yano K. 2003. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18 (1): 32-39.
29. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest 108 (3): 407-414.
30. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, et al. 2004. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22 (10): 1282-1289.
31. Kim SK, Pak HN, Park JH, Fang YF, Kim GI, Park YD, et al. 2010. Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart. Cardiol. Young. 20 (3): 308-317.
32. Kléber AG, and Rudy Y. 2004. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 84 (2): 431-488.
33. Knollmann BC. 2013. Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ. Res. 112 (6): 969-976.
34. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. 2007. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25 (9): 1015-1024.
35. Lammers WJ, Schalij MJ, Kirchhof CJ, and Allessie MA. 1990. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am. J. Physiol 259 (4 Pt 2): H1254-H1263.
36. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, and Charpak S. 2003. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. U. S. A 100 (13): 7808-7811.
37. Li RA. 2012. Gene- and cell-based bio-artificial pacemaker: what basic and translational lessons have we learned? Gene Ther. 19 (6): 588-595.
38. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, et al. 2012. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379 (9819): 895-904.
39. Mazo M, Gavira JJ, Pelacho B, and Prosper F. 2011. Adipose-derived stem cells for myocardial infarction. J. Cardiovasc. Transl. Res. 4 (2): 145-153.
40. McMurray JJ, and Pfeffer MA. 2005. Heart failure. Lancet 365 (9474): 1877-1889.
41. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. 2008. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (9): 1189-1200.
42. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, et al. 2006. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (10): 1287-1294.
43. Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, Lill MC, et al. 2003. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J. Cardiovasc. Electrophysiol. 14 (8): 841-848.
44. Pedrotty DM, Klinger RY, Kirkton RD, and Bursac N. 2009. Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc. Res. 83 (4): 688-697.
45. Pijnappels DA, Schalij MJ, van TJ, Ypey DL, de Vries AA, van der Wall EE, et al. 2006.Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc. Res. 72 (2): 282-291.
46. Pompilio G, Capogrossi MC, Leone AM, and Crea F. 2012. [The SCIPIO and CADUCEUS studies]. G. Ital. Cardiol. (Rome) 13 (12): 777-782.
47. Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S, et al. 2006. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int. J. Cardiol. 111 (2): 231-239.
48. Procida K, Jorgensen L, Schmitt N, Delmar M, Taffet SM, Holstein-Rathlou NH, et al. 2009. Phosphorylation of connexin43 on serine 306 regulates electrical coupling. Heart Rhythm. 6 (11): 1632-1638.
49. Qu Z, Weiss JN, and Garfinkel A. 1999. Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study. Am. J. Physiol 276 (1 Pt 2): H269-H283.
50. Rigol M, Solanes N, Farre J, Roura S, Roque M, Berruezo A, et al. 2010. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J. Card Fail. 16 (4): 357-366.
51. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, et al. 2007. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450 (7171): 819- 824.
52. Rohr S. 2004. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc. Res. 62 (2): 309-322.
53. Rosen MR, Brink PR, Cohen IS, and Robinson RB. 2007. Biological pacemakers based on I(f). Med. Biol. Eng Comput. 45 (2): 157-166.
54. Rubart M, Pasumarthi KB, Nakajima H, Soonpaa MH, Nakajima HO, and Field LJ. 2003. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 92 (11): 1217-1224.
55. Shaw RM, and Rudy Y. 1997. Electrophysiologic effects of acute myocardial ischemia. A mechanistic investigation of action potential conduction and conduction failure. Circ. Res. 80 (1): 124-138.
56. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, et al. 2012. Human ES-cell derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489 (7415): 322-325.
57. Sundelacruz S, Levin M, and Kaplan DL. 2008. Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS. One. 3 (11): e3737.
58. Tan RC, and Joyner RW. 1990. Electrotonic influences on action potentials from isolated ventricular cells. Circ. Res. 67 (5): 1071-1081.
59. Tolmachov O, Ma YL, Themis M, Patel P, Spohr H, Macleod KT, et al. 2006. Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC. Cardiovasc. Disord. 6: 25.
60. Tran DX, Yang MJ, Weiss JN, Garfinkel A, and Qu Z. 2007. Vulnerability to re-entry in simulated two-dimensional cardiac tissue: effects of electrical restitution and stimulation sequence. Chaos. 17 (4): 043115.
61. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, et al. 2007. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 28 (21): 2667-2677.
62. Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B, et al. 2004. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol 555 (Pt 3): 617-626.
63. van Kempen MJ, ten V, I, Wessels A, Oosthoek PW, Gros D, Jongsma HJ, et al. 1995. Differential connexin distribution accommodates cardiac function in different species. Microsc. Res. Tech. 31 (5): 420-436.
64. Wagers AJ, and Weissman IL. 2004. Plasticity of adult stem cells. Cell 116 (5): 639-648.
65. Wiegerinck RF, van Veen TA, Belterman CN, Schumacher CA, Noorman M, de Bakker JM, et al. 2008. Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure. Heart Rhythm. 5 (8): 1178-1185.
66. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. 2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (9429): 141-148.
67. Xie Y, Garfinkel A, Camelliti P, Kohl P, Weiss JN, and Qu Z. 2009. Effects of fibroblast myocyte coupling on cardiac conduction and vulnerability to reentry: A computational study. Heart Rhythm. 6 (11): 1641-1649.